UvA-DARE (Digital Academic Repository) Inflammation in chronic obstructive pulmonary disease : its assessment and the effects of corticosteroids Boorsma, M. Link to publication Citation for published version (APA): Boorsma, M. (2008). Inflammation in chronic obstructive pulmonary disease : its assessment and the effects of corticosteroids. General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: http://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. UvA-DARE is a service provided by the library of the University of Amsterdam (http://dare.uva.nl) Download date: 02 Apr 2019
List of publications
List of publications Zaagsma J, Meems L, Boorsma M. Beta-Adrenoceptor studies. 4. Influence of albumin on in vitro beta-adrenoceptor blocking and antiarrhythmic properties of propranolol, pindolol, practolol and metoprolol. Naunyn Schmiedebergs Arch Pharmacol. 1977;298:29-36. Kraan J, Koëter GH, Van der Mark ThW, Boorsma M, Kukler J, Sluiter HJ, de Vries K. Dosage and time effects of inhaled budesonide on bronchial hyperreactivity. Am Rev Resp Dis 1988;137:44-48. Koëter GH, Kraan J, Boorsma M, Jonkman JHG, Van der Mark ThW. Effect of theophylline and enprofylline on bronchial hyperresponsiveness. Thorax 1989;44:1022-1026. Waalkens H, Gerritsen J, Krouwels F, Koeter G, Boorsma M, Roorda R, van Aalderen W, Knol K. Changes in FEV 1 and PC 20 -histamine in children with mild asthma on treatment with terbutaline and budesonide [Abstract]. Eur Respir J 1989;2 (Suppl 8):778s. Waalkens HJ, Gerritsen J, van Aalderen WM, Koeter GH, Krouwels F, Boorsma M, Roorda RJ, Knol K. Diurnal variation in peak flow rate in children with mild asthma. Effects of treatment with budesonide and terbutaline. Annu Rev Chronopharmacol 1990;7:305-308. Auffarth B, Postma DS, De Monchy JGR, Van der Mark ThW, Boorsma M, Koëter GH. Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness and cough threshold in smokers with chronic obstructive lung disease. Thorax 1991;46:372-377. Pelikan Z, Boorsma M. Effects of intranasal budesonide (BUD) on the early (ENR) and late nasal response (LNR) to challenge (NPT) with bird feces extracts [Abstract]. J Allergy Clin Immunol 1994;93(Suppl):165. Boorsma M, Andersson N, Larsson P, Ullman A. Assessment of the relative systemic potency of inhaled fluticasone and budesonide. Eur Respir J, 1996;9:1427-32. Politiek MJ, Boorsma M, Aalbers R. Comparison of formoterol, salbutamol and salmeterol in methacholine induced severe bronchoconstriction. Eur Respir J 1999;13:988-992. Boorsma M, Lutter R, van de Pol M, Jansen HM, Jonkers RE. Prediction of imminent COPD exacerbations by sputum analysis [Abstract]. Eur Respir J 2003; 22 (suppl 45): 53s. Van der Woude HJ, Boorsma M, Bergqvist PBF, Winter TH, Aalbers R. Budesonide/ formoterol in a single inhaler rapidly relieves methacholine-induced moderate to severe bronchoconstriction. Pulm Pharmacol Ther 2004;17:89-95. Boorsma M, Koopmans J, van de Pol MA, Jansen HM, van der Zee JS, Jonkers RE, Lutter R. Are invalid induced sputum samples characterized by 80% or more of squamous cells? [Abstract]. Eur Respir J. 2005;26 (Suppl 49):373s. Boorsma M, Lutter R, Noorduyn A, Smids B, Jansen HM, Jonkers RE. Airway Granzyme B from CD8+ T-cells is related to severity of airflow obstruction in smokers [Abstract]. Eur Respir J. 2006;28 (Suppl 50):673s. 205
Boorsma M, Lutter R, van de Pol MA, Out TA, Jansen HM, Jonkers RE. Repeatability of inflammatory parameters in induced sputum of COPD patients. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2007;4:321-329. Aalbers R, Mensing M, Boorsma M, Jonkers RE. Protective effect of budesonide/ formoterol in a model of repeated exposure to inhaled adenosine 5 -monophosphate (AMP) in patients with asthma [Abstract]. Eur Respir J 2007;30 (Suppl):353s. Boorsma M, Lutter R, van de Pol M, Out TA, Jansen HM, Jonkers RE. Long term effects of budesonide on inflammatory status in COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2008;5:97-104. Maassen van den Brink KI, Boorsma M, Staal - van den Brekel AJ, Edsbäcker S, Wouters EFM, Thorsson L. Evidence of the in vivo esterification of budesonide in human airways. Br J Clin Pharmacol 2008;66:27-35. Boorsma M, Lutter R, Out TA, Noorduyn LA, Jonkers RE. Cytotoxic CD8+ effector T cells in the lungs of smokers are related to the severity of airflow limitation [Abstract]. Am J Respir Crit Care Med 2008;177 (suppl):a875. Bathoorn E, Liesker JJW, Postma DS, Boorsma M, Bondesson E, Koëter GH, van Oosterhout AJM, Kerstjens HAM. Anti-inflammatory effect of combined budesonide/ formoterol treatment in COPD exacerbations. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2008;5:282-290. 206